> We’re talking about treating very, very large populations, which means that you’re going to see the usual run of mortality and morbidity that you see across large samples.

Exactly, that's why I said when you scale up you will get more absolute deaths and critical conditions. There's no point for those very few deaths or reactions to occur if those people had better natural immunity through previous infection.